UPDATE 1-Valeant to acquire Solta Medical for $236 million
December 16, 2013 at 12:13 PM EST
Dec 16 (Reuters) - Valeant Pharmaceuticals International said on Monday that it would buy Solta Medical Inc for about $236 million in cash to add products for procedures such as skin rejuvenation, skin tightening and body contouring.
